An invalid vocabulary is selected. Please change it in the options.
Title Creditssort ascending Start date - Expiration date
Management of Rare Breast Cancers 0.50 03/15/2020 - 12:00am to 03/15/2021 - 12:00am
Interactive Online Case Studies: Lymphoma - Case 3 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Evidence-Based Approaches to Smoking Cessation in Patients with Cancer 0.50 06/16/2020 - 12:00am to 03/01/2021 - 12:00am
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 2 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Implementing Clinical Trials in the Community Setting 0.50 05/15/2020 - 12:00am to 03/01/2021 - 12:00am
Lymphoma 101: The Plot Thickens 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Interactive Online Case Studies: Plasma Cell Neoplasms - Case 3 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Key Considerations in Adopting a Value-Based Payment Model 0.50 06/25/2020 - 12:00am to 03/01/2021 - 12:00am
Navigating the Jargon of Molecular Testing 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Practical Use of Next Generation Sequencing in Metastatic Disease 0.50 05/08/2020 - 12:00am to 03/01/2021 - 12:00am
Controversies in the Management of Early-Stage Hodgkin Lymphoma 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Interactive Online Case Studies: Leukemia, Myelodysplastic Syndromes, and Myeloproliferative Disorders - Case 2 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Updates in the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Sequencing Therapy and the Role of MRD Testing 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is it Time to Consider CAR T for All? 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am

Pages